Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-05-15
2007-05-15
Mondesi, Robert B. (Department: 1652)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C530S350000, C435S069100
Reexamination Certificate
active
11223294
ABSTRACT:
The RFRP-3 peptide of the present invention which is an agent for promoting prolactin secretion is useful as a prophylactic and/or therapeutic agent for various diseases associated with prolactin secretion, such as hypoovarianism, seminal vesicle hypoplasia, menopausal syndrome and hypothyroidism.
REFERENCES:
patent: WO 00/29441 (2000-05-01), None
patent: WO 01/66134 (2001-09-01), None
patent: WO 02/46405 (2002-06-01), None
S. Hinuma, et al., “New Neuropeptides Containing Carboxy-terminal RFamide and their Receptor in Mammals”, Nature Cell Biology, (2000), pp. 703-708, vol. 2.
Q. Liu, et al., “Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides that Attenuate Morphine-induced Antinociception”, The Journal of Biological Chemistry, (2001), pp. 36961-36969, vol. 276, No. 40.
Habata Yugo
Hinuma Shuji
Hosoya Masaki
Kitada Chieko
Yoshida Hiromi
Butler, Esq. Gregory B.
Conlin, Esq. David G.
Edwards Angell Palmer & & Dodge LLP
Mondesi Robert B.
Takeda Pharmaceutical Company Ltd.
LandOfFree
RFRP-3 and DNA thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RFRP-3 and DNA thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RFRP-3 and DNA thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3793665